Our good AnCan friend, medical journalist Howard Wolinsky, has published an article in the magazine, Chicago Medicine investigating the controversial contrast agent gadolinium used in MRI scanning. Read it here.
This topic is often discussed in AnCan’s Active Surveillance Prostate Cancer Group. Congrats, Howard – c’mon back to our virtual groups to keep us informed!